狂犬病治療薬の世界市場...市場調査レポートについてご紹介

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline

PART 05: Understanding rabies
• Disease overview
• Progression of disease
• Zoonotic diseases in developing countries
• Future prediction and prevention of rabies
• Rabies management: Current scenario

PART 06: Pipeline analysis

PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 08: Market segmentation by application
• Pre-exposure vaccination
• Post-exposure prophylaxis

PART 09: Market segmentation by product type
• CCVs
• RIGs
• NTVs

PART 10: Market segmentation by route of administration
• Intradermal route of administration
• Intramuscular route of administration
• Oral route of administration

PART 11: Geographical segmentation
• Rabies treatment market in Americas
• Rabies treatment market in EMEA
• Rabies treatment market in APAC

PART 12: Decision framework

PART 13: Drivers and challenges
• Market drivers
• Market challenges

PART 14: Market trends
• Zero human rabies by 2030 initiative
• Introduction of monoclonal antibodies
• Growing vendor interest in vaccines with short immunization periods

PART 15: Vendor landscape
• Competitive scenario

PART 16: Key vendor analysis
• Cadila Healthcare
• GlaxoSmithKline
• Merial
• Sanofi
• Other prominent vendors

PART 17: Appendix
• List of abbreviations

[List of Exhibits]

Exhibit 01: Rabies: Stages of disease progression
Exhibit 02: Approaches to rabies management
Exhibit 03: Pipeline summary: Number of drug candidates by product type 2016
Exhibit 04: Pipeline landscape
Exhibit 05: Snapshot of pipeline trends in global rabies treatment market
Exhibit 06: Global rabies treatment market snapshot
Exhibit 07: Global rabies treatment market 2016-2021 ($ millions)
Exhibit 08: Opportunity analysis in global rabies treatment market
Exhibit 09: Five forces analysis
Exhibit 10: Global rabies treatment market by application
Exhibit 11: Global rabies treatment market by application: Consumption scenario in developing versus developed countries 2016
Exhibit 12: Market segmentation based on product type
Exhibit 13: Global rabies treatment market by product type 2016
Exhibit 14: Global CCV for rabies treatment market 2016-2021 ($ millions)
Exhibit 15: Global RIG for rabies treatment market 2016-2021 ($ millions)
Exhibit 16: Global NTV for rabies treatment market 2016-2021 ($ millions)
Exhibit 17: Market segmentation based on route of administration
Exhibit 18: Global rabies treatment market share by route of administration 2016
Exhibit 19: Global rabies treatment market by geography 2016 and 2021
Exhibit 20: Global rabies treatment market revenue by geography 2016-2021 ($ millions)
Exhibit 21: Global rabies treatment market share by geography 2016-2021
Exhibit 22: Market scenario in Americas
Exhibit 23: Rabies treatment market in Americas 2016-2021 ($ millions)
Exhibit 24: Market scenario in EMEA
Exhibit 25: Rabies treatment market in EMEA 2016-2021 ($ millions)
Exhibit 26: Market scenario in APAC
Exhibit 27: Rabies treatment market in APAC ($ millions)
Exhibit 28: Competitive structure analysis of global rabies treatment market 2016
Exhibit 29: Cadila Healthcare: Key highlights
Exhibit 30: Cadila Healthcare: Strength assessment
Exhibit 31: Cadila Healthcare: Strategy assessment
Exhibit 32: Cadila Healthcare: Opportunity assessment
Exhibit 33: GlaxoSmithKline: Key highlights
Exhibit 34: GlaxoSmithKline: Strength assessment
Exhibit 35: GlaxoSmithKline: Strategy assessment
Exhibit 36: GlaxoSmithKline: Opportunity assessment
Exhibit 37: Merial: Key highlights
Exhibit 38: Merial: Strength assessment
Exhibit 39: Merial: Strategy assessment
Exhibit 40: Merial: Opportunity assessment
Exhibit 41: Sanofi: Key highlights
Exhibit 42: Sanofi: Strength assessment
Exhibit 43: Sanofi: Strategy assessment
Exhibit 44: Sanofi: Opportunity assessment